West Pharmaceutical Services, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 872.3M | 844.9M | 805.0M | 804.3M | 766.2M | 698.2M | 748.5M | 746.9M |
| Cost of Goods Sold | 543.1M | 548.5M | 501.1M | 510.8M | 493.0M | 465.5M | 474.1M | 481.7M |
| Gross Profit | 329.2M | 296.4M | 303.9M | 293.5M | 273.2M | 232.7M | 274.4M | 265.2M |
| R&D Expenses | 19.7M | 15.8M | 21.8M | 17.1M | 19.1M | 16.3M | 18.5M | 15.5M |
| Operating Expenses | 150.1M | 119.3M | 146.8M | 119.8M | 115.0M | 104.3M | 103.8M | 97.4M |
| Operating Income | 179.1M | 177.1M | 156.6M | 173.7M | 158.2M | 128.4M | 170.6M | 167.8M |
| Other Income / Gains | 1.0M | 3.0M | 8.8M | 300K | 3.8M | -14.5M | -3.7M | 600K |
| Net Income | 154.0M | 138.8M | 132.1M | 140.0M | 131.8M | 89.8M | 130.1M | 136.0M |
| EPS (Diluted) | 2.17 | 1.93 | 1.83 | 1.94 | 1.82 | 1.24 | 1.79 | 1.87 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.377 | 0.351 | 0.378 | 0.365 | 0.357 | 0.333 | 0.367 | 0.355 |
| General And Administrative Expenses | 117.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 117.6M | 99.5M | 106.5M | 102.7M | 95.9M | 88.0M | 85.3M | 81.9M |
| Other Expenses | 12.8M | 4.0M | 18.5M | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 693.2M | 667.8M | 647.9M | 630.6M | 608.0M | 569.8M | 577.9M | 579.1M |
| Interest Income | 1.2M | 3.2M | 5.3M | 4.7M | 3.6M | 4.1M | 4.8M | 4.6M |
| Interest Expense | 0 | 0 | 0 | 100K | 100K | 400K | 0 | 700K |
| Depreciation And Amortization | 0 | 44.6M | 47.0M | 43.0M | 41.4M | 40.0M | 40.7M | 40.2M |
| Ebitda | 179.1M | 218.5M | 209.5M | 217.1M | 198.5M | 150.9M | 205.6M | 205.4M |
| Ebitdaratio | 0.205 | 0.259 | 0.26 | 0.27 | 0.259 | 0.216 | 0.275 | 0.275 |
| Operating Income Ratio | 0.205 | 0.21 | 0.195 | 0.216 | 0.206 | 0.184 | 0.228 | 0.225 |
| Income Before Tax | 180.1M | 180.1M | 165.4M | 174.0M | 162.0M | 113.9M | 166.9M | 168.4M |
| Income Before Tax Ratio | 0.206 | 0.213 | 0.205 | 0.216 | 0.211 | 0.163 | 0.223 | 0.225 |
| Income Tax Expense | 32.2M | 44.7M | 33.3M | 34.0M | 30.2M | 24.1M | 36.8M | 32.4M |
| Net Income Ratio | 0.177 | 0.164 | 0.164 | 0.174 | 0.172 | 0.129 | 0.174 | 0.182 |
| Epsdiluted | 2.15 | 1.92 | 1.82 | 1.93 | 1.82 | 1.23 | 1.78 | 1.85 |
| Weighted Average Shs Out | 70.8M | 72.0M | 72.3M | 72.3M | 72.3M | 72.5M | 73.0M | 72.8M |
| Weighted Average Shs Out Dil | 71.3M | 72.4M | 72.7M | 72.7M | 72.8M | 73.0M | 73.7M | 73.4M |